Table 5.
Secondary outcomes of included studies.
Study | Ischemic | Hemorrhagic | Neurological deficits | Other |
---|---|---|---|---|
Morgan et al. (20) | 0 | 0 | 0 | 0 |
Jafar et al. (21) | 1 (3.7) | NR | 1 (3.7) | NR |
Xu et al. (24) | 1 (4.55) | 0 | 0 | 0 |
Ishishita et al. (27) | 1 (2.7) | 0 | 0 | 2 (5.41) |
Kalani et al. (28) | 0 | 1 (4) | 1 (4) | 1 (4) |
Rustemi et al. (29) | 1 (4.55) | 0 | 0 | 0 |
Nussbaum et al. (33) | 6 (6.32) | 7 (7.37) | 4 (4.21) | 7 (7.37) |
Natarajan et al. (36) | 3 (14.29) | NR | NR | NR |
Dodier et al. (38) | 1 (2.7) | 0 | 0 | 4 (10.81) |
Data presented as n (%). NR, non-reported.